Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Study of the Effect of Thalidomide Combined With Megestrol Acetate on Lymphocyte, Inflammatory Factor Regulation and Nutritional Status in Patients With Advanced Malignant Tumors

NCT03777930 is registered in ClinicalTrials.gov with Shenzhen Fifth People's Hospital as lead sponsor.

NCT NCT03777930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03777930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Study of the Effect of Thalidomide Combined With Megestrol Acetate on Lymphocyte, Inflammatory Factor Regulation and Nutritional Status in Patients With Advanced Malignant Tumors
Lead sponsor
Shenzhen Fifth People's Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
December 10, 2018
Completion date
June 10, 2021
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, therapy-related